Does Autoimmunity Increase Biological Age?

Autoimmune diseases are associated with increased biological age — meaning that people living with conditions such as rheumatoid arthritis, lupus, or Hashimoto’s thyroiditis may show cellular and molecular markers of aging beyond what their chronological age would predict. This association is driven largely by chronic inflammation, immune dysregulation, and cumulative cellular damage. That said, the relationship is not uniform: the degree of acceleration varies considerably depending on the condition, its severity, and how well it is managed.

Autoimmunity and Biological Age: The Core Relationship

What Is Biological Age?

Biological age reflects how well the body is functioning at a cellular and systemic level, in contrast to chronological age, which simply counts years lived. Tools such as epigenetic clocks — which measure DNA methylation patterns — telomere length, and inflammatory biomarkers can all provide estimates of biological age. Importantly, these measures can diverge significantly from chronological age, particularly in the presence of chronic disease.

In autoimmune conditions, persistent immune activation places sustained stress on tissues, cells, and regulatory systems. As a result, biological age markers may shift in a direction consistent with accelerated aging, even in relatively young individuals.

What the Evidence Shows

Research using epigenetic clocks has found that several autoimmune conditions — including rheumatoid arthritis and systemic lupus erythematosus — are associated with measurably higher biological age compared to healthy controls of the same chronological age. Studies suggest this gap can range from a few years to over a decade in some conditions, though estimates vary considerably across studies and populations.

It is important to note that these findings reflect population-level associations. Not every person with an autoimmune condition will experience the same degree of biological age acceleration. Factors such as disease activity, treatment response, comorbidities, and lifestyle all influence the overall picture. For broader context on how the immune system changes with age, see our guide on immune aging and chronic inflammation.

How Autoimmunity May Accelerate Biological Aging

Chronic Inflammation as the Primary Driver

The most well-established mechanism linking autoimmunity to biological aging is chronic, low-grade inflammation — sometimes referred to as inflammaging when it occurs in the context of aging itself. In autoimmune conditions, however, this inflammatory state is driven not only by aging but by ongoing immune misactivation targeting the body’s own tissues.

Elevated levels of pro-inflammatory cytokines — such as IL-6, TNF-alpha, and IL-1β — are common in active autoimmune disease. These signals promote DNA damage, disrupt mitochondrial function, and contribute to telomere shortening, all of which are established hallmarks of cellular aging. In this sense, autoimmune inflammation and inflammaging overlap significantly, even though their origins differ.

Cellular Senescence

Autoimmune-driven tissue damage can push cells into senescence — a state in which cells cease dividing but remain metabolically active, secreting pro-inflammatory factors known as the senescence-associated secretory phenotype (SASP). This creates a feedback loop: senescent cells amplify local inflammation, which in turn promotes further cellular stress and senescence. Evidence suggests that this process contributes meaningfully to the tissue-level aging seen in chronic autoimmune conditions, though the precise magnitude of this contribution in humans remains an active area of research.

Immune System Dysregulation

Autoimmune diseases often involve patterns of immune dysregulation that resemble features of immunosenescence — the gradual decline in immune competence that occurs with normal aging. These include a reduction in regulatory T cell function, altered B cell activity, and increased production of autoantibodies. Collectively, these changes impair the immune system’s ability to distinguish self from non-self, regulate inflammatory responses, and repair damaged tissues efficiently.

In effect, the immune system in autoimmune disease can appear and behave as though it is biologically older than its chronological counterpart. This overlap between autoimmune dysregulation and normal immune aging is one reason researchers are increasingly interested in their shared mechanisms. For a deeper look at how declining immune surveillance relates to mortality risk, see our article on whether immunosenescence increases mortality risk.

Managing Autoimmunity to Support Healthier Aging

Reducing Inflammatory Burden

Effective control of disease activity is likely the most important lever for reducing autoimmune-related biological age acceleration. When inflammation is well managed — through appropriate medical treatment, lifestyle factors, or both — the downstream cellular damage associated with chronic immune activation is reduced. Research suggests that achieving sustained remission in conditions like rheumatoid arthritis is associated with improvements in biological aging markers, though this evidence is still developing.

From a lifestyle perspective, anti-inflammatory dietary patterns, regular moderate exercise, and adequate sleep all support immune regulation and reduce systemic inflammatory burden. These are not cures, but they represent meaningful adjuncts to medical management. Learn more in our complete guide to longevity at longevityinsights.co.uk/what-is-longevity/.

Nutrients That Support Immune Regulation

Certain nutrients play a role in supporting immune balance in the context of autoimmunity and aging. Vitamin D is particularly relevant — deficiency is common in autoimmune conditions and has been linked to impaired immune regulation. Omega-3 fatty acids have established anti-inflammatory properties and may help modulate the intensity of autoimmune responses. Zinc and selenium both support normal immune function and antioxidant defences, though supplementation above adequate levels offers no clear additional benefit in well-nourished individuals.

These nutrients should be framed as supportive of normal immune function, not as treatments for autoimmunity or as proven means of reversing biological aging. The evidence for specific supplementation protocols in autoimmune-related aging is limited in humans at present.

Emerging Directions

Research into senolytic therapies — agents designed to selectively clear senescent cells — and epigenetic reprogramming represents an early but promising area for addressing immune-related biological aging. Clinical evidence in humans remains limited, and these approaches are not yet available as standard interventions. However, they highlight the growing recognition that autoimmune-driven cellular aging may eventually be addressable at a mechanistic level, beyond simply managing symptoms.

For now, the most evidence-supported approach remains consistent disease management combined with lifestyle strategies that reduce inflammatory burden and support overall cellular health. Research in this area is active, and the picture will likely become clearer over the next decade. You can also explore how chronic inflammation more broadly relates to healthspan in our article on whether chronic inflammation shortens lifespan.

References and Resources

Conclusion

Research consistently links autoimmune disease to accelerated biological aging, primarily through chronic inflammation, cellular senescence, and immune dysregulation. However, this is an association — not an inevitability. The degree to which autoimmunity accelerates biological age depends heavily on disease type, activity level, and how effectively it is managed. Effective disease control, combined with lifestyle strategies that reduce inflammatory burden, represents the most evidence-grounded approach to preserving healthspan in the context of autoimmune disease. The mechanisms involved are complex and research is ongoing, but the practical message is clear: managing immune dysregulation matters not just for symptom control, but for long-term biological health.